Saudi Delegation Highlights Kingdom’s Evolving Global Growth Story at World Economic Forum
20.1.2023 20:37:00 EET | Business Wire | Press release
Saudi Arabia’s smart city NEOM offers a new model for environmentally-friendly and sustainable urban design, both for the Kingdom and the world, Saudi’s Climate Envoy told the World Economic Forum (WEF) today.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230120005356/en/
Saudi’s Climate Envoy speaks at the World Economic Forum about creating sustainable future cities (Photo: AETOSWire)
During a panel session titled ‘The Evolution of Urban Life’, His Excellency Adel bin Ahmed Al-Jubeir, Minister of State for Foreign Affairs and Climate Envoy for Saudi Arabia, said: “[The Line] will revolutionize the way people look at cities and urban planning. NEOM is an attempt to create a city that is environmentally friendly, sustainable, that has a very high quality of life, that has virtually no traffic.”
His Excellency Khalid bin Abdulaziz Al-Falih, Minister of Investment, participated in a session called ‘Reshuffling Value Chains’. He described how Saudi Arabia’s supply chain initiatives will leverage the Kingdom’s resources, infrastructure, and location to enhance local and global supply chain resilience.
“In Saudi Arabia, we launched the Global Supply Chain Resilience Initiative (GCSRI), to not only strengthen our resilience but also enable the Kingdom to become part of the global multi-hub system, while playing to our strengths.”
During a session titled Deployment in the Industrial Metaverse, His Excellency Abdullah bin Amer Alswaha, Minister of Communications & Information Technology, said: “The current 2D world that we live in today is not fit for purpose in the 21st century.
“I'm a big advocate of the metaverse, which is going to be the next wave of how immersive experiences work for consumers, enterprises, and industry. We are bringing together academics, innovators, policymakers and regulators into a sandbox to make sure that they have a safe environment to innovate.”
His Excellency Faisal F. Alibrahim, Saudi Arabia’s Minister of Economy and Planning told the WEF audience the Kingdom is set to surpass projected growth rates for 2023.
“Saudi is becoming the global growth story. We had the strongest growth in the G20 last year and if you look more closely at the 8.5 percent GDP growth figure, you will see that our non-oil activities and our private sector grew at a very high rate,” he said.
Earlier, Alibrahim addressed a panel on global tax reform, where he said: “Under Saudi Vision 2030, we have been focusing on detaching ourselves from traditional sources of revenue, with our economic diversification, to think about more long-term sustainable revenue generation, but also diversifying our sources of growth.”
In addition to the panel sessions, the Ministry of Economy and Planning for Saudi Arabia joined forces with WEF’s open innovation platform UpLink to launch a challenge designed to enhance food security in countries with arid climates. The Food Ecosystems and Arid Climates Challenge is a global call for technology solutions to food insecurity.
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230120005356/en/
Contact information
Wooud Alquaied
walquaied@mep.gov.sa
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 05:00:00 EEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 02:51:00 EEST | Press release
Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equity among HCPs, patients, regulators and other stakeholders. A global leader in women’s health, the company’s portfolio includes more than 70 products across Women’s Health and General Medicines, which includes biosimila
PMC Organometallix Announces Price Increase on All Products25.4.2026 00:02:00 EEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi ® arbitral award in favor of AOP Health24.4.2026 19:52:00 EEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
Compass Pathways Announces FDA Granted NDA Rolling Review Request and Awarded Commissioner's National Priority Voucher24.4.2026 17:37:00 EEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced the U.S. Food and Drug Administration (FDA) granted Compass NDA rolling review request and selected COMP360, Compass’ proprietary formulation of synthetic psilocybin, for the Commissioner's National Priority Voucher (CNPV) program for treatment-resistant depression (TRD). Companies selected for the voucher program will be entitled to benefits including enhanced communications and a shortened 1-2 month review time following filing of a New Drug Application (NDA), while maintaining FDA’s rigorous safety and efficacy standards. “We are honored and grateful to be selected for the CNPV which is a clear validation of both the urgent unmet need facing millions of people living with treatment resistant depression and the innovative science of COMP360,” said Kabir Nath, Chief Executive Officer of Compass Pathways. “As the most advan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom